The Board of Bloomage BioTechnology Corporation Limited announced that with effect from 29 October 2013, Mr. Jin Xuekun has been re-designated from an independent non-executive Director to an executive Director. Furthermore, Mr. Jin has been appointed to replace Ms. Liu Aihua as the chief executive officer of the company with an effective date to be determined. Ms. Liu Aihua will remain as an executive Director upon her resignation as the chief executive officer of the company.

Mr. Jin has resigned and Mr. Zhang Fuping has been appointed as a member of the Audit Committee; Mr. Jin has resigned as a member of the Nomination Committee, Mr. Zhang Fuping has resigned as the chairman (but remain as a member) of the Nomination Committee and Ms. Zhang Lili has been appointed as a member and the chairman of the Nomination Committee; and Mr. Jin has resigned as the chairman (but remain as a member) of the Remuneration Committee, Ms. Wang Aihua has resigned as a member of the Remuneration Committee and Mr. Zhang Fuping has been appointed as a member and the chairman of the Remuneration Committee. Mr. Jin Xuekun has over 20 years' experience in the sale and marketing of medical instruments and he was able to bring remarkable improvements to the performance and results of the companies he worked at during his service in these companies. He worked at China Rehabilitation Research Center from 1987 to 1993 and was responsible for medical imaging.

He worked at Chindex (Beijing) International Trade Company Limited from 2001 to 2006 as vice president and was responsible for the marketing of medical imaging equipment in the PRC.